Industry News
Long non-coding RNAs
Thanks to support from the Balnaves Foundation, postdoctoral researcher Dr Jennifer Lynch will explore long non-coding RNAs as potential new targets for treating childhood leukaemia.
[ + ]Minimising the damage of stroke
The finding that certain peptides have highly neuroprotective properties in stroke models may lead to a treatment that limits brain damage after stroke.
[ + ]$1.9m to support Australia-India research fund
The Australia-India Strategic Research Fund (AISRF) - Australia's largest fund dedicated to bilateral research - will receive $1.9 million in government funding to support 10 collaborative projects. [ + ]
$1.9m to support Australia-India research fund
The Australia-India Strategic Research Fund (AISRF) - Australia's largest fund dedicated to bilateral research - will receive $1.9 million in government funding to support 10 collaborative projects. [ + ]
Boosting treatments for inflammatory diseases
New treatments for arthritis, multiple sclerosis and other auto-inflammatory diseases may be on the horizon with the development of a small molecule that blocks a key process in inflammation. [ + ]
Annual survey of Australia's biotech industry closing soon
The annual AusBiotech CEO Industry Position Survey is in its final weeks of data collection and biotech industry leaders (CEOs, MDs) are urged to assist industry development with experiences, knowledge, key metrics and political insight. [ + ]
Anatara's Detach reduces piglet mortality in farm trial
Anatara Lifesciences (ASX:ANR) said its Detach product was able to reduce piglet mortality compared with a placebo during an on-site trial at a Victorian farm.
[ + ]Medvet licenses cell line for cancer antibody
Medvet Science has licensed the XL-99 cell line from ACYTE Biotech and plans to use the line for the development of a monoclonal antibody with applications in cancer diagnostics and treatment.
[ + ]Three Industry Growth Centre chairs appointed
Minister for Industry and Science Ian Macfarlane today announced chairs for three of the federal government's Industry Growth Centres, as well as an independent advisory committee.
[ + ]Call for transitional arrangements for R&D Tax incentive cap
The passage of legislation last week to cap claims on the Research and Development (R&D) Tax Incentive and its retrospective application to 1 July 2014 has prompted calls for the government to provide transitional arrangements for biotech companies abandoned in a difficult position.
[ + ]Starpharma 1H losses grow on trial spending
Starpharma (ASX:SPL) reported a wider net loss for the first half of FY15 on increased clinical trial spending, but a capital raising left the company in an improved cash position.
[ + ]Breath test for lung cancer to be trialled this year
UK-based company Owlstone Nanotech has devised the LuCID (Lung Cancer Indicator Detection) project - an attempt to non-invasively diagnose lung cancer by measuring volatile organic compounds (VOCs) in patients' breath. [ + ]
2015 Fulbright Scholars announced
The Australian-American Fulbright Commission has selected its Australian scholars for 2015. The Fulbright Scholarships support students and scholars, chosen for their academic merit and leadership potential, to research and study in each other's countries, exchange ideas and develop bilateral relations and connections to address common issues. [ + ]
New scientific adviser for Humane Research Australia
Humane Research Australia (HRA), a not-for-profit organisation which promotes humane, non-animal methods of research, has appointed Dr Brett Lidbury to its advisory panel. [ + ]
Genes for obesity
Over 100 new genetic regions that control obesity and fat distribution have been identified in a collaborative study involving Australian researchers. [ + ]